ArticleAmerican journal of translational research2025

CDC42: unlocking a novel therapeutic target for primary sclerosing cholangitis through Mendelian randomization.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.